Brain perfusion CT compared with15O-H2O-PET in healthy subjects by Julie Grüner et al.
ORIGINAL RESEARCH Open Access
Brain perfusion CT compared with15O-H2O-PET in
healthy subjects
Julie Marie Grüner*†, Rune Paamand†, Liselotte Højgaard† and Ian Law†
Abstract
Background: Regional cerebral blood flow [rCBF] measurements are valuable for identifying angiogenically active
tumours, and perfusion computed tomography [CT] has been suggested for that purpose. This study aimed to
validate rCBF measurements by perfusion CT with positron-emission tomography [PET] and15O-labelled water [15O-
H2O] in healthy subjects.
Methods: RCBF was measured twice in 12 healthy subjects with15O-H2O PET and once with perfusion CT
performed over the basal ganglia. Matching rCBF values in regions of interest were compared.
Results: Measured with perfusion CT, rCBF was significantly and systematically overestimated. White matter rCBF
values were 17.4 ± 2.0 (mean ± SD) mL min-1 100 g-1 for PET and 21.8 ± 3.4 mL min-1 100 g-1 for perfusion CT.
Grey matter rCBF values were 48.7 ± 5.0 mL min-1 100 g-1 for PET and 71.8 ± 8.0 mL min-1 100 g-1 for perfusion
CT. The overestimation of grey matter rCBF could be reduced from 47% to 20% after normalization to white
matter rCBF, but the difference was still significant.
Conclusion: RCBF measured with perfusion CT does contain perfusion information, but neither quantitative nor
relative values can substitute rCBF measured by15O-H2O PET yet. This, however, does not necessarily preclude a
useful role in patient management.
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Background
Quantitative measurement of the regional cerebral blood
flow [rCBF] is a fundamental physiological parameter for
characterizing the status of the brain tissue. RCBF mea-
surements have important clinical implications in defin-
ing tissue ischemia [1,2], in diagnosing
neurodegenerative diseases [3], and in locating and
monitoring angiogenically active tumour tissues [4,5].
Positron-emission tomography [PET] measurements
using a freely diffusible tissue tracer, oxygen-15-labelled
water [15O-H2O], is regarded as one of the rCBF gold
standards [6-8]. This cumbersome technique requires
on-line tracer production from a cyclotron and continu-
ous arterial blood sampling. It is expensive, technically
demanding, and traumatic for the patient, and is rarely
found outside specialized hospital units. An attractive
alternative to PET would be dynamic contrast-enhanced
computed tomography [CT] or perfusion CT. Perfusion
CT methodology has improved profoundly in recent
years. It is now a practical technique for the clinical
environment due to the development and broad intro-
duction of fast multidetector row CT systems, increasing
computer power, new image acquisition protocols, and
commercially available perfusion softwares [1]. It is also
relatively cheap, easy, and rapid to perform. Further-
more, in many acute medical and surgical conditions,
such as stroke, head injury, and subarachnoid haemor-
rhage, and in radiotherapy planning, cerebral CT scan-
ning is often the primary imaging modality of choice.
This makes perfusion CT particularly applicable for
additional tissue characterization [9]. Another interest-
ing application has arisen with the advent of hybrid ima-
ging techniques such as PET/CT and single photon
emission computed tomography/CT. In the same exami-
nation, and with only minor additional scan time, perfu-
sion CT can be considered as an adjunct to further
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visualize the vascular physiology of relevant lesions. This
complements and extends the physiological tissue infor-
mation obtained by PET, e.g. the glucose metabolism
using18F-fluorodeoxyglucose [10] or hypoxia using18F-
fluoromisonidazole [11].
However, the underlying kinetic models for rCBF
measured by perfusion CT and PET with15O-H2O differ
fundamentally. Perfusion CT is based on the dynamic
behaviour of an intravascular contrast agent, while15O-
H2O PET models a freely diffusible tissue tracer. To
investigate this further, we compared the rCBF measure-
ments of the two techniques directly in the same healthy
subjects on the same day within a few hours.
Materials and methods
Subjects
Seventeen healthy volunteers were recruited to the pro-
tocol and scanned from August 2008 to April 2009. All
subjects underwent a structured interview of health his-
tory. The exclusion criteria were a known neurological
disease, migraine, reduced renal function, pregnancy,
and a known allergy against iodinated contrast media.
All subjects gave oral and written informed consents
according to the Helsinki II Declaration. The plasma
creatinine levels of all subjects were measured within 2
weeks before the scan and were all within a normal
range. One subject was excluded because of a technical
failure in the CT iv-contrast power injector; two subjects
were excluded because of failure in the arterial blood
sampling during PET scanning; one subject was
excluded as the arterial catheter could not be placed
correctly; and in one subject, the rCBF PET kinetic
modelling failed. Consequently, 12 volunteers (nine
females, three males) were available for analysis with a
median age of 24 years (range 20 to 26 years). The pro-
tocol was approved by the Committee on Biomedical




A dedicated brain high-resolution research tomograph
PET scanner (CTI/Siemens, Knoxville, TN, USA) was
used for all PET scans. This scanner has an axial field of
view of 25 cm and a near-isotropic resolution of 2 mm.
PET tracer
An 800-MBq15O-H2O was produced on-line and injected
intravenously in an antecubital vein via an automatic
water injection system [AWIS] (1997, Scansys, Værløse,
Denmark). AWIS delivered a 16-mL bolus over 10 s with
both pre- and after-flush of an inert saline solution [7].
Each volunteer had two tracer injections. A short indwel-
ling catheter was placed in the non-dominant radial
artery under local anaesthesia for blood sampling.
Image acquisition
During scanning, the subject’s head was rested in a
foam-cushioned headrest, and a head strap was used to
minimize head movement. Initially, a 6-min transmis-
sion scan with a rotating137Cs single-photon point
source was performed for attenuation correction. The 7-
min emission scans were acquired in a three-dimen-
sional [3D] list mode and initiated immediately before
tracer injection. The interscan interval was at least 10
min to allow for isotope decay.
For kinetic modelling, arterial blood was sampled con-
tinuously during the scans using an automatic blood
sampling system [ABSS] (Allogg, Mariefred, Sweden) set
to draw arterial blood at a constant speed of 8 mL/min
with its activity measured every 0.5 s. The inner dia-
meter of the tube connected to the arterial catheter was
1.0 mm. Immediately after the scan, 2 mL of arterial
blood was drawn for blood gas analysis to evaluate the
physiologic respiratory state of the subjects. The samples
were analysed for arterial partial pressures of oxygen
[PaO2] and carbon dioxide [PaCO2], saturation level of
oxygen [sO2], and haemoglobin concentration [ctHb]
(ABL 700 Series, Radiometer Medical, Copenhagen,
Denmark). The detectors in the ABSS and the PET
scanner were cross-calibrated against an independent
dose calibrator so that all data could be reported in
radioactivity concentration (in becquerel per millilitre).
Image reconstruction
Dynamic images were reconstructed using a 3D-ordered
subset expectation maximization algorithm with correc-
tion for the measured point spread function into 40
frames per scan with durations of 1 × 30, 18 × 5, 9 ×
10, 10 × 15, and 2 × 30 s. Each frame consisted of 207
image planes in a 256 × 256 matrix with an isotropic
voxel size of 1.22 × 1.22 × 1.22 mm3. The first 30-s
frame was designed to accommodate the tracer delay
from injection to the brain tissue. All images were cor-
rected for dead time and scatter and filtered with a 3D
Gaussian 5-mm filter.
PET CBF calculation
Using a commercially available software package, PMOD
3.0 (PMOD Technologies, Zürich, Switzerland), the
dynamic images of the first 210 s following the arrival of
activity to the brain and the delay- and dispersion-cor-
rected arterial input functions [12] were fitted by
Alpert’s one-tissue compartment model [13] according
to Equation 1:
Ct(t) = fCa(t) ⊗ e−(f /Vd)t (1)
where Ct(t) denotes tissue activity concentration (in
becquerel per millilitre), Ca(t) is the measured arterial
input function (in becquerel per millilitre), f is the rCBF
(in millilitre per minute per 100 g), and Vd (in millilitre
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per gram) is the fitted volume of distribution. ⊗ repre-
sents the convolution operation. This generated the
parametric images of rCBF.
Radiation dose
The dose equivalent following PET transmission and
emission scans was in a total of 1.6 mSv: 0.1 mSv for




A Biograph 40 TruePoint PET/CT scanner (Siemens,
Knoxville, TN, USA) was used.
Contrast media
A preheated iso-osmolar iodine contrast medium
OptiRay 350 (Ioversol 350 mg/mL, Tyco Healthcare,
Neustadt an der Donau, Bayern, Germany) was injected
intravenously by a power injector (OptiVantage DH
Injection System, Liebel-Flarsheim, Cincinnati, OH,
USA) as a short bolus of 40 mL (8 mL/s) through a
catheter in the antecubital vein followed by 20 mL of
saline solution.
Image acquisition
In nine subjects, PET scanning was performed before
CT, and in three subjects, CT before PET. A lateral
scout scan at the angle of the meato-orbital plane was
performed followed by a non-enhanced low dose CT
(120 kVp, 40 mAs). This guided the selection of four
contiguous transaxial slices at the anatomical level of
the third ventricle and through the basal ganglia, which
is the level most frequently used in perfusion CT stroke
evaluations. The orbits were not in the field of view to
avoid unnecessary irradiation to the lens. The contrast
medium was injected 4 s before the initiation of the
dynamic scan. The dynamic scan consisted of 160
images: one image for 40 s over four slices of 7.2-mm
thick at 80 kVp and 120 mAs. The arterial cannula from
the PET scan was kept in place and used to draw arter-
ial blood for blood gas analysis immediately after the
scan.
Image reconstruction and rCBF calculation
Each slice was reconstructed into a 512 × 512 image
matrix using a H30s medium smooth kernel. Voxel
dimensions were non-isotropic 0.44 × 0.44 × 7.2 mm3.
The rCBF was calculated in a semi-automated manner
using a commercial software, Syngo Neuro Perfusion
CT 2006A (Siemens, Knoxville, TN, USA). After seg-
mentation and removal of an extra cerebral tissue, a cir-
cular reference region of interest [ROI] was defined
automatically in the occipital part of the superior sagittal
sinus. Maximum intensity projection [MIP] CTs were
reconstructed to enhance areas of high radiodensity that
are useful for identifying vascular structures. Regions
with larger vessels were excluded in the rCBF
assessments by thresholding the MIP CT image by 15%
of the maximal value corresponding to a regional cere-
bral blood volume [rCBV] threshold of 14.4 mL/100
mL. The arterial input function was derived from the
time-attenuation curve from ROIs comprising both
anterior cerebral arteries in cross section, and the rCBF
(in millilitre per minute per 100 mL) was calculated
using a deconvolution approach. By dividing with the
brain tissue density of 1.04 g/mL, the rCBF values were
converted into units per weight tissue as for rCBF PET.
Radiation dose
The effective dose equivalent was 2.9 mSv for the CT
perfusion protocol.
Data analysis
Image co-registration and ROIs
Using PMOD, rCBF PET, rCBF CT, and MIP CT
images were co-registered to the low-dose CT scan of
the head to a final voxel size of 0.5 × 0.5 × 1.5 mm3.
This was done to insure that all ROIs referred to and
included an identical tissue composition across techni-
ques. On the MIP CT images, 14 ROIs were drawn in
symmetrical areas over the grey matter in the head of
the caudate nuclei, putamen, frontal cortex, temporal/
parietal cortex, occipital cortex, and anterior and poster-
ior white matter (Figure 1, top). By using a masking
technique on the rCBF CT images, values below zero
inside ROIs were excluded from analysis. In one subject,
the putamen could not be drawn because it was only
partly included in the scanned area. Finally, the 14 ROIs
were projected onto identical areas of the masked para-
metric rCBF PET and rCBF CT images for quantifica-
tion. The tissue volume in the ROIs ranged from 109 to
407 mm3 (average 247 mm3). We then calculated the
volume-weighted average white and grey matter values
based on the selected ROIs.
Statistical methods
The statistical analysis was conducted using MATLAB
(MathWorks Inc., Natick, MA, USA). Paired t tests with
a two-tailed significance level of a = 0.05 was used to
evaluate the blood gas data. A similar method was used
for the analyses between rCBF CT and the average of
two rCBF PET scans for white and grey matter ROIs.
In the quantitative assessment of rCBF using PET, CT,
and magnetic resonance imaging [MRI], it is recognized
that the global variation in CBF may have a significant
impact on the regional variation [15-18]. We, thus,
repeated the comparison of grey matter values after nor-
malization to the volume-weighted average of the four
white matter ROIs. The two-tailed significance level for
the paired t tests was at a = 0.05, but a Bonferroni cor-
rection was applied for multiple non-independent com-
parisons. Thus, the thresholds were p < 0.0036 (14
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comparisons) and p < 0.005 (10 comparisons) for the
quantified and white matter normalized analyses,
respectively.
The Bland-Altman test [19] was used to assess the
agreement between corresponding grey matter measure-
ments. The mean difference, standard deviations, and the
95% limits of agreement were calculated and plotted. The
rCBF measures were plotted against each other for each
subject individually using linear regression analyses; the
linear slopes were determined; and the coefficient of deter-
mination [r2] between the two methods was calculated.
Results
Blood gas analyses
Air bubbles in one syringe and malfunction of one
arterial catheter left a total of 11 subjects for this analy-
sis (Table 1). There was no significant change in blood
gas levels and haemoglobin concentration between the
first and the second PET scan. However, when compar-
ing the averaged blood gas levels of the two PET scans
to the gas values measured immediately after CT, there
was a modest, but significant drop in PaCO2 of approxi-
mately 0.3 kPa or 2 mmHg. At the same time, there was
Figure 1 Co-registered transaxial slices through the level of the basal ganglia. Co-registered transaxial slices showing MIP from perfusion
CT integrated over 40 s (left), the rCBF images using PET (centre), and perfusion CT (right) quantified in millilitre per minute per 100 g. For a
better comparison, the rCBF PET and rCBF CT images are displayed in different scales. The top row shows the location and configuration of ROIs
in the frontal cortex (dark blue), parietal cortex (light blue), occipital cortex (green), caudate nucleus (red), putamen (yellow), frontal white matter
(purple), and occipital white matter (orange). High-intensity areas in the MIP images represent larger vascular volumes around the vessels of the
cortex and insula, the choroid plexus, and the sinuses. These are partly, but not completely, removed by masking the rCBF CT images. This
discrepancy between the two techniques is evident around a right-sided occipital vein that is visualised in rCBF CT, but not in rCBF PET (white
arrow, bottom row).
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a slight, but non-significant (p = 0.07), increase in PaO2
of approximately 1.0 kPa or 7 mmHg. The data indicate
slight hyperventilation during the performance of perfu-
sion CT and confirm that no discernable effects of the
approximately 100-mL blood drawn during PET scan-
ning could be found in the haemoglobin concentration.
RCBF measures
There was no significant difference between the two
rCBF PET measurements. The absolute measurements
are summarised in Table 2. The average volume-
weighted rCBF PET measurements were 17.4 ± 2.0 mL
min-1 100 g-1 (mean ± standard deviation) for the white
matter and 48.7 ± 5.0 mL min-1 100 g-1 for the grey
matter with a between-subject regional coefficient of
variance [COV] in the 10% to 17% range. In all regions
but one white matter ROI, the absolute rCBF measure-
ments with perfusion CT were significantly higher than
the PET measurements even after a rigid Bonferroni
correction. The average volume-weighted rCBF mea-
surements with perfusion CT were 21.8 ± 3.4 mL min-1
100 g-1 for the white matter and 71.8 ± 8.0 mL min-1
100 g-1 for the grey matter. The COVs were higher than
the rCBF PET measurements in 11 of 14 ROIs ranging
from 11% to 28%. The mean increase compared to rCBF
PET was 4.4 ± 3.3 mL min-1 100 g-1 in the white matter
and 23.1 ± 8.5 mL min-1 100 g-1 in the grey matter
(Table 2). The lower and upper 95% limits of the grey
and white matter changes from PET to CT rCBF were
-8.0 and 43.4 mL min-1 100 g-1, respectively (Figure 2).
The overall mean volume-weighted grey matter/white
matter ratio was 2.78 ± 0.25 for rCBF PET, and it was
significantly higher for perfusion CT, 3.34 ± 0.48 (Table
3). On the regional level, the ratios were significantly
higher in the right caudate nucleus, in the frontal and
parietal cortices, and in the left parietal cortex. Interest-
ingly, compared to the absolute measurements, the
regional COVs were reduced in seven out of ten regions
for rCBF PET, but increased in eight out of ten for
rCBF CT. Thus, normalization to the white matter
reduced the volume-weighted grey matter COV for
rCBF PET from 10.4% to 9.1%, while it was increased
for rCBF CT from 11.2% to 14.3%.
The Bland-Altman plots demonstrated a bias for rCBF
CT that increases from lower to higher mean grey and
white matter values (Figure 2). The linear slopes
between the two methods when including both white
and grey matter values were significantly different from
zero in all individuals with an average r2 of 0.89 (range
0.82 to 0.96) and an average slope of 1.56 (range 1.20 to
Table 1 Blood gas measurements
RCBF PET RCBF CT
(n = 11) Mean ± SD Mean ± SD p Value
PaCO2 (kPa) 5.51 ± 0.50 5.23 ± 0.42 < 0.01
PaO2 (kPa) 13.80 ± 1.37 14.77 ± 1.19 NS
ctHb (mmol/L) 8.22 ± 0.69 8.12 ± 0.73 NS
sO2 (%) 0.98 ± 0.01 0.99 ± 0.00 NS
RCBF, regional cerebral blood flow; CT, computed tomography; PET, positron-
emission tomography; SD, standard deviation; NS, non-significant; PaCO2,
arterial tension of carbon dioxide; PaO2, arterial tension of oxygen; ctHb,
haemoglobin concentration; sO2, oxygen saturation.
Table 2 RCBF measurements from PET and perfusion CT scanning
PET COV CT COV ΔCBF
Side ROI Mean ± SD % Mean ± SD % Mean ± SD p Value
Right Caudate nucleus 48.7 ± 6.3 12.9 71.6 ± 10.1 14.2 22.9 ± 12.2 < 0.05
Putamen 50.5 ± 7.1 14 73.9 ± 13.9 18.7 21.5 ± 13.9 < 0.05
Frontal cortex 49.4 ± 6.8 13.7 74.4 ± 9.1 12.3 25.0 ± 9.3 < 0.05
Parietal cortex 45.0 ± 6.7 14.9 72.0 ± 8.5 11.8 27.1 ± 10.7 < 0.05
Occipital cortex 45.1 ± 5.7 12.7 68.5 ± 15.5 22.7 23.4 ± 15.3 < 0.05
Anterior white matter 17.6 ± 3.0 17.1 18.9 ± 5.2 27.7 1.3 ± 5.9 NS
Posterior white matter 18.0 ± 2.5 14.1 22.5 ± 4.2 18.7 4.5 ± 3.7 < 0.05
Left Caudate nucleus 49.7 ± 4.9 9.9 69.6 ± 10.7 15.4 19.9 ± 10.6 < 0.05
Putamen 51.3 ± 5.1 10 73.0 ± 11.9 16.4 19.9 ± 11.8 < 0.05
Frontal cortex 51.5 ± 6.3 12.3 73.3 ± 9.2 12.6 21.8 ± 8.7 < 0.05
Parietal cortex 46.8 ± 5.5 11.8 73.3 ± 8.3 11.4 26.5 ± 8.7 < 0.05
Occipital cortex 46.4 ± 7.2 15.6 67.1 ± 15.9 23.7 20.6 ± 14.0 < 0.05
Anterior white matter 18.4 ± 2.9 15.5 23.2 ± 3.9 17 4.8 ± 4.8 < 0.05
Posterior white matter 16.5.± 2.0 12 22.7 ± 4.4 19.4 6.2 ± 4.3 < 0.05
Volume weighted white matter 17.4 ± 2.0 11.7 21.8 ± 3.4 15.8 4.4 ± 3.3 < 0.05
Volume weighted grey matter 48.7 ± 5.0 10.4 71.8 ± 8.0 11.2 23.1 ± 8.5 < 0.05
CBF, cerebral blood flow; PET, positron-emission tomography; CT, computed tomography; ROI, region of interest; SD, standard deviation; COV, coefficient of
variance; NS, non-significant. N = 12. RCBF units are in millilitre per minute per 100 g. The p values are Bonferroni-corrected.
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Figure 2 Bland-Altman plot of the difference between rCBF CT and rCBF PET against their mean values. The middle line indicates the
mean difference. The outer lines indicate 95% limits of agreement. The rCBF CT values are biased and are all larger than the rCBF PET values,
and the difference increases with increasing mean rCBF values. Cross mark, grey matter; empty circle, white matter.
Table 3 Relative rCBF grey matter measurements from PET and perfusion CT scanning normalized to white matter
PET COV CT COV ΔCBF
Side ROI Mean ± SD % Mean ± SD % Mean ± SD p Value
Right Caudate nucleus 2.77 ± 0.26 9.4 3.32 ± 0.55 16.6 0.56 ± 0.40 < 0.05
Putamen 2.90 ± 0.30 10.4 3.39 ± 0.62 18.3 0.44 ± 0.65 NS
Frontal cortex 2.81 ± 0.30 10.5 3.47 ± 0.60 17.2 0.66 ± 0.52 < 0.05
Parietal cortex 2.56 ± 0.35 13.6 3.37 ± 0.67 19.8 0.81 ± 0.67 < 0.05
Occipital cortex 2.58 ± 0.34 13.3 3.17 ± 0.64 20.2 0.59 ± 0.72 NS
Left Caudate nucleus 2.84 ± 0.33 11.6 3.24 ± 0.62 19 0.40 ± 0.45 NS
Putamen 2.96 ± 0.28 9.4 3.36 ± 0.66 19.7 0.37 ± 0.66 NS
Frontal cortex 2.94 ± 0.31 10.4 3.41 ± 0.56 16.3 0.48 ± 0.52 NS
Parietal cortex 2.67 ± 0.34 12.7 3.43 ± 0.64 18.5 0.76 ± 0.70 < 0.05
Occipital cortex 2.65 ± 0.40 15 3.12 ± 0.77 24.8 0.47 ± 0.69 NS
Volume weighted grey matter 2.78 ± 0.25 9.1 3.34 ± 0.48 14.3 0.56 ± 0.47 < 0.05
CBF, cerebral blood flow; PET, positron-emission tomography; CT, computed tomography; ROI, region of interest; SD, standard deviation; COV, coefficient of
variance; NS, non-significant. N = 12. The p values are Bonferroni-corrected.
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2.17; Figure 3). When only the grey matter regions were
analysed, the slopes were only significant in 4 of 12 sub-
jects. These four subjects had r2 of 0.40 to 0.50 and
slopes between 0.5 and 1.75.
Discussion
In this study, we have compared the quantitative rCBF
values that can be obtained by two imaging techni-
ques,15O-H2O PET and perfusion CT. To date, studies
that directly validate perfusion CT in healthy subjects
have been very scarce. The majority of studies concern
patients with cerebrovascular disease, and validation has
been against either the stable xenon-CT method [20,21]
or15O-H2O PET [22]. Although rCBF can be derived
from the non-ischemic hemisphere in stroke patients,
the design is suboptimal. It is quite possible that regio-
nal perfusion in the undamaged hemisphere is
influenced to some degree by either a subclinical tissue
pathology, a generalised micro- or macrovascular dis-
ease, remote functional effects of neural damage (dia-
schisis), or a co-morbidity (cardiac function, pulmonary
disease). Particularly the quality of the bolus input gives
errors in the rCBF determination, e.g. bolus buffering in
the lungs. Therefore, a reduced cardiac output will sys-
tematically decrease rCBF [23]. Similarly, in patients
with carotid occlusion, selection of a single arterial
input function will cause increased delay and dispersion
of the contrast agent to the ischemic areas and thus,
underestimate rCBF by 15% to 20% [24].
As the greater part of the validation studies is aimed
at cerebrovascular diseases, the regions used focus on
the major cerebral artery territories or whole hemi-
spheres. Thus, the rCBF measures are a heterogeneous
mixture derived from both the white and grey matter
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Figure 3 Scatter plot of rCBF CT against rCBF PET. Linear regression lines are shown for each subject (n = 12). The line of perfect agreement
is indicated. The rCBF CT values are clearly biased towards higher rCBF values, and the regression slopes are all above 1.0. Cross mark, grey
matter; empty circle, white matter.
Grüner et al. EJNMMI Research 2011, 1:28
http://www.ejnmmires.com/content/1/1/28
Page 7 of 10
tissues, vascular volumes, and cerebrospinal fluid spaces,
but the relative weights of the individual tissue compo-
nents are unknown [21,22,24-26]. This will render direct
comparison between our quantitative grey matter rCBF
CT values and these studies difficult.
In studies where the white and grey matter rCBF CT
values are available, these range from 14 to 30 mL min-1
100 g-1 and 40 to 70 mL min-1 100 g-1, respectively,
with a COV of 25% to 30% [6,20,23,27]. Although
mostly derived from patient studies, these results are
quite similar to the results we found in normal healthy
subjects. We found average volume-weighted rCBF CT
measurements of 21.8 ± 3.4 mL min-1 100 g-1 for the
white matter and 71.8 ± 8.0 mL min-1 100 g-1 for the
grey matter. The relative regional between-subject COV
ranged from 11% to 28%. The rCBF CT values were sig-
nificantly larger than the average volume-weighted rCBF
PET measurements by 25% in the white matter and 47%
in the grey matter. The absolute values were 17.4 ± 2.0
mL min-1 100 g-1 for the white matter and 48.7 ± 5.0
mL min-1 100 g-1 for the grey matter with a COV in the
10% to 17% range. Our findings correspond to the
values previously reported in the literature using this
technique [7,8,13,28,29]. In a larger Japanese study
encompassing 70 healthy subjects spanning 11 institu-
tions, the overall average rCBF for cerebral cortical
regions were 42.7 ± 6.3 mL min-1 100 g-1 with a COV
of 14.6% [30].
When normalizing to the white matter, the relative
regional grey matter COV was nominally lower with
PET compared to CT in 10 of 14 ROIs. One explanation
for the lower COV with PET was that we used the aver-
age of two measurements. This was not done for perfu-
sion CT to keep the radiation dose within acceptable
limits. To our knowledge, a test-retest study of baseline
rCBF CT has not been reported on healthy subjects.
In the study design, we have tried to limit the varia-
tion between the two techniques further by performing
same-day measurements within 1 to 2 h. A further
source of variation, which has not been considered in
previous validation studies, is the impact that changes of
the pre-scan arterial blood gas status might have on
rCBF [29]. The PaCO2 decreased significantly by 2
mmHg from PET to CT scanning, suggesting slight
hyperventilation. Hyperventilation decreases rCBF by
washing out PaCO2 by approximately 2% per millimetre
of mercury [31,32]. This would decrease the rCBF CT
measurements by 4% and further increase the difference
between techniques if corrected for. The hyperventila-
tion itself may have been caused by anticipatory anxiety
in the CT scanning session possibly associated to the
procedure itself. Mood states in scanning sessions have
been investigated by Matthew et al. [28], and a trend
was found for anticipatory anxiety to be lowered from
the first to second scans. This may have been forestalled
by letting the subjects rest in the CT scanner for several
minutes before scans and maybe even perform a ‘sham-
scan’ before scans.
The bias between techniques was not constant, but
increased with the increasing rCBF value (Figure 2),
which indicates a logarithmic influence. It is possible
that there are global effects in a measurement that influ-
ences the regional values. This could be between-subject
differences, physiological fluctuations, or methodological
errors pertaining to the measurement of the input func-
tion and the involved corrections [32,33] or in the selec-
tion of the venous ROI and the arterial input function
in perfusion CT [23,34]. One strategy is to normalize
the rCBF to the tissue that systematically co-varies with
the global fluctuations and is not affected by isolated
pathological processes. We examined this hypothesis
using the white matter as a reference tissue. For the
overall grey matter, the normalized rCBF in perfusion
CT was only 20% larger than that for PET. Thus, more
than half of the difference between techniques can be
explained by global fluctuations affecting both tissues
alike, but there is a residual effect manifest as a larger
contrast between the white and grey matter tissues in
perfusion CT. Interestingly, normalization to the white
matter reduced the grey matter COV in PET, but
increased the COV in perfusion CT, indicating that
there are individual grey/white matter differences to be
considered. Thus, prior to the use of tissue normaliza-
tion in a clinical setting, it is essential that effects of bias
and noise are well understood.
One aspect that also needs to be examined is the
effect of differences in resolution, the partial volume
effect [PVE]. The PVE will of course affect not only
PET values, but also PCT values, as the resolution of
both methods is insufficient to accurately quantify the
rCBF in the cortical grey matter. The object of the
paper, however, was not so much to measure ‘true’ cor-
tical rCBF, but to compare two methods under clinical
conditions. So the strategy was to have the PVE affect
the two methods to the same degree, rather than to
introduce a new level of complexity and potential bias
by PVE correction through e.g. tissue-segmented MRI.
This was done by securing comparable image resolu-
tions and an accurate image registration between the
two imaging modalities. Thus, any error caused by tissue
heterogeneity in a given ROI would affect the sampled
values to the same degree. We do not believe that the
differences between methods can be related to image
resolution.
The two methods,15O-H2O-PET and perfusion CT,
are inherently different since perfusion CT relies on the
dynamic behaviour of a non-diffusible intravascular
iodine medium, whereas15O-H2O-PET relies on a tracer
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that is freely diffusible into the tissues. Strictly speaking,
the term ‘rCBF’ should only be reserved to denote the
volume flow rate of blood though a functional tissue
that has the ability to exchange nutrients and waste pro-
ducts, thus, the capillary blood flow. However, a purely
intravascular tracer, as iodine contrast, will distribute to
all vascular segments. Thus, a fundamental flaw with
perfusion CT is the presence of high-contrast signals in
regions without a functional tissue and a capillary bed
such as the choroid plexus, arteries, arterioles, venules,
veins, and sinuses. An example can be seen in Figure 1,
where a draining vein in the left occipital region has an
rCBF signal increase on perfusion CT without any dis-
cernable signal on15O-H2O-PET, indicating the absence
of a functional tissue. The most common strategy is to
eliminate vascular pixels in the CT images before calcu-
lation of rCBF. A simple regional rCBV threshold of 8
mL/100 g has been suggested as the most accurate [6].
This threshold, however, was not feasible in our study
as large and irregular sections of the brain parenchyma
were excluded from analyses. We, thus, chose a thresh-
old of 14.4 mL/100 g that respected tissue integrity and
kept the rCBF CT images legible for clinical use. The
grey matter rCBV has been measured to 3 to 4 mL/100
g [30,35], so both thresholds are somewhat above the
normal tissue rCBV level. In the ROI definitions, we
carefully omitted obvious larger vascular structures, but
there is definitely a contribution from smaller non-capil-
lary vessels and probably also from a PVE from larger
vessels. We regard that the blood volume influenced the
signal as the dominant error source in the overestima-
tion of rCBF CT values, in the increased contrast
between the white and grey matter, and as an important
regional noise contribution. This has been recognized
previously as well [6,36,37].
Although biased, we found that the rCBF CT does
correlate with rCBF PET for each individual over a
broad range of values from the white to the grey matter
(Figure 3), but poorly if only grey matter rCBF values
were considered. Previous studies in patients have found
r2 ranging from 0.5 to 0.8 with significant linear regres-
sion slopes of 0.7 to 1.4 [20,22,38,39] and in healthy
subjects, r2 from 0.4 to 0.9 with slopes 1.0 to 1.55
[6,25]. The significant correlations signify that rCBF CT
does deliver a perfusion-weighted signal, but with a ten-
dency to overestimate the values particularly for highly
perfused regions.
Conclusion
Although perfusion CT is an attractive, widely avail-
able, relatively cheap, rapid, and easily performed
method, we have not been able to confirm some of the
previously published reports of high accuracy per-
formed mainly on patients with cerebrovascular
disease. Perfusion CT is not accurate enough in the
current setting. In healthy subjects, perfusion CT does
deliver a perfusion-weighted signal, but with a ten-
dency to overestimate the values particularly for highly
perfused regions. The average overestimation of rCBF
in the grey matter of 47% is unacceptably high. Neither
with respect to absolute quantification nor perfusion
distribution can rCBF CT measures substitute rCBF
PET, primarily because of the confounding effects of
blood volume. This does not exclude a useful role in
patient management, which must, however, be evalu-
ated in separate investigations with the normative data
in mind.
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